Photo credit: commons.wikimedia.org

“I buy on the assumption that they could close the market the next day and not reopen it for five years.”

— Warren Buffett

The investment philosophy practiced by Warren Buffett calls for investors to take a long-term horizon when making an investment, such as a five year holding period (or even longer), and reconsider making the investment in the first place if unable to envision holding the stock for at least five years. Today, we look at how such a long-term strategy would have done for investors in CME Group (NASD: CME) back in 2018, holding through to today.

Start date: 01/18/2018
$10,000

01/18/2018
  $13,604

01/17/2023
End date: 01/17/2023
Start price/share: $152.21
End price/share: $175.99
Starting shares: 65.70
Ending shares: 77.30
Dividends reinvested/share: $31.30
Total return: 36.05%
Average annual return: 6.35%
Starting investment: $10,000.00
Ending investment: $13,604.65

As shown above, the five year investment result worked out well, with an annualized rate of return of 6.35%. This would have turned a $10K investment made 5 years ago into $13,604.65 today (as of 01/17/2023). On a total return basis, that’s a result of 36.05% (something to think about: how might CME shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

Beyond share price change, another component of CME’s total return these past 5 years has been the payment by CME Group of $31.30/share in dividends to shareholders. Automatic reinvestment of dividends can be a wonderful way to compound returns, and for the above calculations we presume that dividends are reinvested into additional shares of stock. (For the purpose of these calcuations, the closing price on ex-date is used).

Based upon the most recent annualized dividend rate of 4/share, we calculate that CME has a current yield of approximately 2.27%. Another interesting datapoint we can examine is ‘yield on cost’ — in other words, we can express the current annualized dividend of 4 against the original $152.21/share purchase price. This works out to a yield on cost of 1.49%.

One more investment quote to leave you with:
“We ignore outlooks and forecasts… we’re lousy at it and we admit it … everyone else is lousy too, but most people won’t admit it.” — Martin Whitman